Department of Surgery News & Announcements

Congratulations to physician scientist Dr. Yael Mosse, who received a Penn Medicine Award of Excellence for her contributions to pediatric oncology, and more.

Improving clinical care is at the heart of the Craniofacial Program, designated as a new Frontier Program at CHOP.

Discover new tools that streamline germline classification and cluster patterns in spatial transcriptomics data in this week’s research news.

In this week’s news, our researchers have developed the first-of-its-kind bone marrow atlas and innovative, painless wound dressings. Read on to learn more.

This week, honors for innovative CHOP investigators, early results of gene editing for inherited blindness, plus ASGCT and PAS meeting highlights.

News highlights this week include the Biomedical Technician Training Program recognition event, new COVID-19 outcomes research, and more.

William Peranteau, MD, along with CHOP and Penn researchers are developing “one-and-done” new base-editing therapies for three genetic diseases of newborns.

This milestone represents an important step in treatment options for patients with hereditary hearing loss caused by genetic mutations.

The American Society for Bone and Mineral Research honored Dr. Fanxin Long for his signification contributions to the field.

The new Center for Outcomes Research in Surgery provides a patient-centered approach to improving outcomes in children with surgical conditions.

This week’s news roundup features three studies, Doris Duke Award winners, and a commitment to the CHOP Parkway Run & Walk.

Celebrating the launch of the Center for Outcomes REsearch in Surgery (CORES) at CHOP

A new study has found that, contrary to popular belief, firearm deaths in the U.S. are statistically more likely in small towns rather than big cities.

Learn about novel findings from our Children’s Hospital of Philadelphia researchers.

Philadelphia Regional Center for Children’s Environmental Health takes on environment threats to children in the area’s most vulnerable communities.

Pediatric KIDney Stone Care Improvement Network is all about collaborative, partnership-based, patient-centered kidney stone research.

The Emerging Innovators at CHOP Research Institute cover a variety of scientific disciplines.

Identified by CHOP researchers, palovarotene is the first drug approved (in Canada) for fibrodysplasia ossificans progressiva, a severe bone disease.

A rare disease hack-a-thon leads to an unusual collaboration between D3b’s bioinformaticians, including Adam Resnick, PhD, and American Airlines’ software engineers.

Please join us in congratulating the work and accomplishments of our distinguished faculty who have been recently promoted.

CHOP researchers identified the drug, palovarotene, to treat fibrodysplasia ossificans progressive (FOP).

This week’s research news features Surgeon-in-Chief, Scott Adzick, MD, and a significant CHOP milestone: the 2,000th fetal surgery birth

This week’s research news features CHOP Oncologist Stephen Hunger, MD, as quoted in a “TODAY Show” article about pediatric cancer research.

New findings from the latest MOMS2 analysis show prenatal repair of the spinal column confers physical gains that extend into childhood.

Our most engaging stories of 2020 highlight moments of positivity, hope, and inspiration in a year of challenge and change.

MOMS2 research demonstrates benefits of fetal surgery for spina bifida continue to school-age children.

William Peranteau, MD, receives NIH grant to study in utero gene editing treatment for congenital monogenic disorders.